874 related articles for article (PubMed ID: 34303328)
21. Tumor-associated macrophages: an accomplice in solid tumor progression.
Chen Y; Song Y; Du W; Gong L; Chang H; Zou Z
J Biomed Sci; 2019 Oct; 26(1):78. PubMed ID: 31629410
[TBL] [Abstract][Full Text] [Related]
22. Tumor-associated macrophages in multiple myeloma: advances in biology and therapy.
Sun J; Park C; Guenthner N; Gurley S; Zhang L; Lubben B; Adebayo O; Bash H; Chen Y; Maksimos M; Muz B; Azab AK
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35428704
[TBL] [Abstract][Full Text] [Related]
23. The Role of Tumor-Associated Macrophages in the Progression and Chemoresistance of Ovarian Cancer.
Nowak M; Klink M
Cells; 2020 May; 9(5):. PubMed ID: 32456078
[TBL] [Abstract][Full Text] [Related]
24. Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers.
Xu T; Yu S; Zhang J; Wu S
J Hematol Oncol; 2021 Oct; 14(1):181. PubMed ID: 34717710
[TBL] [Abstract][Full Text] [Related]
25. Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy.
Toledo B; Zhu Chen L; Paniagua-Sancho M; Marchal JA; Perán M; Giovannetti E
J Hematol Oncol; 2024 Jun; 17(1):44. PubMed ID: 38863020
[TBL] [Abstract][Full Text] [Related]
26. Tumor-Associated Macrophage Subsets: Shaping Polarization and Targeting.
Zhang Q; Sioud M
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108657
[TBL] [Abstract][Full Text] [Related]
27. Tumor promoting role of anti-tumor macrophages in tumor microenvironment.
Goswami KK; Ghosh T; Ghosh S; Sarkar M; Bose A; Baral R
Cell Immunol; 2017 Jun; 316():1-10. PubMed ID: 28433198
[TBL] [Abstract][Full Text] [Related]
28. The role of tumor-associated macrophages in osteosarcoma progression - therapeutic implications.
Huang Q; Liang X; Ren T; Huang Y; Zhang H; Yu Y; Chen C; Wang W; Niu J; Lou J; Guo W
Cell Oncol (Dordr); 2021 Jun; 44(3):525-539. PubMed ID: 33788151
[TBL] [Abstract][Full Text] [Related]
29. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy.
Cao Y; Qiao B; Chen Q; Xie Z; Dou X; Xu L; Ran H; Zhang L; Wang Z
Acta Biomater; 2023 Apr; 160():239-251. PubMed ID: 36774974
[TBL] [Abstract][Full Text] [Related]
30. Targeting tumor-associated macrophages: A potential treatment for solid tumors.
Chen Y; Jin H; Song Y; Huang T; Cao J; Tang Q; Zou Z
J Cell Physiol; 2021 May; 236(5):3445-3465. PubMed ID: 33200401
[TBL] [Abstract][Full Text] [Related]
31. Interaction of tumor‑associated macrophages with stromal and immune components in solid tumors: Research progress (Review).
Kazakova A; Sudarskikh T; Kovalev O; Kzhyshkowska J; Larionova I
Int J Oncol; 2023 Feb; 62(2):. PubMed ID: 36660926
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive Integrative Analysis Reveals the Association of
Arora S; Singh P; Ahmad S; Ahmad T; Dohare R; Almatroodi SA; Alrumaihi F; Rahmani AH; Syed MA
Cells; 2021 Aug; 10(8):. PubMed ID: 34440860
[TBL] [Abstract][Full Text] [Related]
33. Phosphoinositide 3-kinase/Akt and its related signaling pathways in the regulation of tumor-associated macrophages polarization.
Yang D; Yang L; Cai J; Li H; Xing Z; Hou Y
Mol Cell Biochem; 2022 Oct; 477(10):2469-2480. PubMed ID: 35590082
[TBL] [Abstract][Full Text] [Related]
34. The role of macrophages in the tumor microenvironment and tumor metabolism.
Sadhukhan P; Seiwert TY
Semin Immunopathol; 2023 Mar; 45(2):187-201. PubMed ID: 37002376
[TBL] [Abstract][Full Text] [Related]
35. Cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs); where do they stand in tumorigenesis and how they can change the face of cancer therapy?
Tajaldini M; Saeedi M; Amiriani T; Amiriani AH; Sedighi S; Mohammad Zadeh F; Dehghan M; Jahanshahi M; Zanjan Ghandian M; Khalili P; Poorkhani AH; Alizadeh AM; Khori V
Eur J Pharmacol; 2022 Aug; 928():175087. PubMed ID: 35679891
[TBL] [Abstract][Full Text] [Related]
36. Exosome-mediated communication between tumor cells and tumor-associated macrophages: implications for tumor microenvironment.
Han C; Zhang C; Wang H; Zhao L
Oncoimmunology; 2021 Feb; 10(1):1887552. PubMed ID: 33680573
[TBL] [Abstract][Full Text] [Related]
37. Targeting tumor-associated macrophages as an antitumor strategy.
Cheng N; Bai X; Shu Y; Ahmad O; Shen P
Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
[TBL] [Abstract][Full Text] [Related]
38. CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer.
Lin L; Chen YS; Yao YD; Chen JQ; Chen JN; Huang SY; Zeng YJ; Yao HR; Zeng SH; Fu YS; Song EW
Oncotarget; 2015 Oct; 6(33):34758-73. PubMed ID: 26416449
[TBL] [Abstract][Full Text] [Related]
39. Tumor‑associated macrophages in lung cancer: Friend or foe? (Review).
Xu F; Wei Y; Tang Z; Liu B; Dong J
Mol Med Rep; 2020 Nov; 22(5):4107-4115. PubMed ID: 33000214
[TBL] [Abstract][Full Text] [Related]
40. Nanomedicine-based cancer immunotherapies developed by reprogramming tumor-associated macrophages.
Li X; Guo X; Ling J; Tang Z; Huang G; He L; Chen T
Nanoscale; 2021 Mar; 13(9):4705-4727. PubMed ID: 33625411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
